Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 314

1.

Recombinant human Fab antibody fragments to HIV-1 Rev and Tat regulatory proteins: direct selection from a combinatorial phage display library.

Pilkington GR, Duan L, Zhu M, Keil W, Pomerantz RJ.

Mol Immunol. 1996 Mar-Apr;33(4-5):439-50.

PMID:
8676895
2.

B-cell epitopes in HIV-1 Tat and Rev proteins colocalize with T-cell epitopes and with functional domains.

Tähtinen M, Ranki A, Valle SL, Ovod V, Krohn K.

Biomed Pharmacother. 1997;51(10):480-7.

PMID:
9863510
3.

Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes.

Hinkula J, Svanholm C, Schwartz S, Lundholm P, Brytting M, Engström G, Benthin R, Glaser H, Sutter G, Kohleisen B, Erfle V, Okuda K, Wigzell H, Wahren B.

J Virol. 1997 Jul;71(7):5528-39.

5.

Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals.

Reiss P, de Wolf F, Kuiken CL, de Ronde A, Dekker J, Boucher CA, Debouck C, Lange JM, Goudsmit J.

J Acquir Immune Defic Syndr. 1991;4(2):165-72.

PMID:
1898969
6.

Inhibition of Tat-mediated transactivation and HIV-1 replication by human anti-hCyclinT1 intrabodies.

Bai J, Sui J, Zhu RY, Tallarico AS, Gennari F, Zhang D, Marasco WA.

J Biol Chem. 2003 Jan 17;278(3):1433-42. Epub 2002 Oct 24.

7.

Recombinant human monoclonal Fab fragments against rotavirus from phage display combinatorial libraries.

Itoh K, Nakagomi O, Suzuki K, Inoue K, Tada H, Suzuki T.

J Biochem. 1999 Jan;125(1):123-9.

8.

Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual.

Iversen AK, Shpaer EG, Rodrigo AG, Hirsch MS, Walker BD, Sheppard HW, Merigan TC, Mullins JI.

J Virol. 1995 Sep;69(9):5743-53.

10.
11.

Human recombinant antibody fragments specific for a rye-grass pollen allergen: characterization and potential applications.

de Lalla C, Tamborini E, Longhi R, Tresoldi E, Manoni M, Siccardi AG, Arosio P, Sidoli A.

Mol Immunol. 1996 Sep;33(13):1049-58.

PMID:
9010244
12.

Cloning and molecular characterization of a human recombinant IgG Fab binding to the Tat protein of human immunodeficiency virus type 1 (HIV-1) derived from the repertoire of a seronegative patient.

Mancini N, Perotti M, Carletti S, Canducci F, Sampaolo M, Clementi M, Burioni R.

Mol Immunol. 2006 Mar;43(9):1363-9. Epub 2005 Sep 30.

PMID:
16199090
14.

Fab'-induced folding of antigenic N-terminal peptides from intrinsically disordered HIV-1 Tat revealed by X-ray crystallography.

Serrière J, Dugua JM, Bossus M, Verrier B, Haser R, Gouet P, Guillon C.

J Mol Biol. 2011 Jan 7;405(1):33-42. doi: 10.1016/j.jmb.2010.10.033. Epub 2010 Oct 28. Review.

PMID:
21035463
17.
18.

Compatibility of Tat and Rev transactivators in the primate lentiviruses.

Sakai H, Sakuragi J, Sakuragi S, Kawamura M, Adachi A.

Arch Virol. 1993;129(1-4):1-10. Review.

PMID:
8385908
19.

Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy.

Duan L, Zhu M, Ozaki I, Zhang H, Wei DL, Pomerantz RJ.

Gene Ther. 1997 Jun;4(6):533-43. Erratum in: Gene Ther 1998 Apr;5(4):570.

20.

Enhanced endocytosis and anti-human immunodeficiency virus type 1 activity of anti-rev antibodies after cationization.

Pardridge WM, Bickel U, Buciak J, Yang J, Diagne A.

J Infect Dis. 1994 Jan;169(1):55-61.

PMID:
8277198

Supplemental Content

Support Center